Product Name: Sitagliptin CAS NO:486460-32-6
Chemical & Physical Properties:
Appearance : White to off-white power
Boiling Point:529.905℃ at 760 mmHg
Sitagliptin is the first dipeptidyl peptidase-4 (DPP-4) inhibitor approved for the treatment of type 2 diabetes, which can prevent and treat type 2 diabetes, hyperglycemia, insulin resistance, obesity and hypertension And certain complications. Sitagliptin phosphate was developed by Merck and was launched in Mexico and the United States in 2006. It was approved by the European Union in 2007 for the treatment of type 2 diabetes. At present, sitagliptin phosphate tablets have become the second largest oral diabetes drug in the United States.
If you are interested in our products or have any questions, please feel free to contact us!
Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.